Penicillin G Procaine (Pro-Pen-G)

Penicillin G Procaine stands as one of the most fundamental and widely utilized antibiotics in livestock medicine, representing decades of proven efficacy against susceptible bacterial infections in farm animals. This beta-lactam antibiotic combines the bactericidal properties of penicillin G with the procaine salt formulation, which creates a repository effect that extends the duration of therapeutic blood levels following intramuscular or subcutaneous injection. The procaine component serves as a local anesthetic, reducing injection site discomfort while simultaneously slowing the absorption of penicillin G from the injection site to provide sustained antimicrobial activity over an extended period.

The mechanism of action of Penicillin G Procaine involves interference with bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) located on the inner membrane of bacterial cells. This binding inhibits the transpeptidation reaction necessary for cross-linking the peptidoglycan chains that provide structural integrity to bacterial cell walls. Without functional cell wall synthesis, susceptible bacteria undergo osmotic lysis and death. This bactericidal mechanism makes penicillin G particularly effective against actively dividing bacteria, as cell wall synthesis is essential during bacterial replication and growth phases.

Penicillin G Procaine is available exclusively as an injectable aqueous suspension formulation for intramuscular or subcutaneous administration in livestock species. The suspension contains fine particles of penicillin G procaine that form a depot at the injection site, releasing the antibiotic gradually over approximately 24 hours. Common concentrations include 300,000 units per milliliter, though combination products with penicillin G benzathine may contain different unit concentrations to provide both immediate and prolonged antimicrobial activity.

From a regulatory standpoint, Penicillin G Procaine holds FDA approval for use in multiple food-producing animal species including cattle, swine, sheep, and horses. Many formulations are available over-the-counter without a prescription, making this antibiotic accessible for on-farm treatment of common bacterial infections. However, producers must strictly adhere to labeled withdrawal times to ensure meat and milk safety for human consumption. The established withdrawal periods reflect the time required for tissue residues to fall below safe tolerances established by regulatory agencies.

Penicillin G Procaine carries labeled indications for treating a broad spectrum of bacterial infections in cattle, swine, sheep, and other livestock species caused by penicillin-susceptible organisms. The primary targets include gram-positive bacteria such as Streptococcus species, Staphylococcus aureus, Clostridium species, Erysipelothrix rhusiopathiae, and Actinomyces bovis. Additionally, certain gram-negative organisms including Pasteurella multocida and Fusobacterium necrophorum demonstrate susceptibility to penicillin G at therapeutic concentrations, expanding the clinical utility of this medication.

In cattle, Penicillin G Procaine serves as a first-line treatment for numerous bacterial conditions encountered in beef and dairy operations. Bovine respiratory disease complex involving Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni responds to penicillin therapy when initiated early in the disease course. Foot rot caused by Fusobacterium necrophorum and Bacteroides melaninogenicus represents another common indication where penicillin demonstrates reliable efficacy. Additional cattle applications include treatment of wooden tongue (actinobacillosis), lumpy jaw (actinomycosis), wound infections, post-surgical prophylaxis, and certain cases of metritis in dairy cows.

Swine producers frequently utilize Penicillin G Procaine for treatment of erysipelas caused by Erysipelothrix rhusiopathiae, a significant bacterial pathogen in pig production. The characteristic diamond skin lesions and potential for chronic arthritis or endocarditis make prompt treatment essential. Streptococcal infections including Streptococcus suis, respiratory infections, and wound management also fall within the therapeutic scope of penicillin in swine operations. The medication proves valuable for treating individual sick pigs as well as managing disease outbreaks when early intervention can limit spread.

Sheep and goats benefit from Penicillin G Procaine treatment for foot rot, pneumonia, wound infections, and clostridial disease. The medication effectively addresses Fusobacterium necrophorum in ovine foot rot cases and supports treatment of respiratory infections caused by Mannheimia haemolytica. Clostridial diseases including blackleg, malignant edema, and enterotoxemia may incorporate penicillin therapy alongside appropriate antitoxin administration.

Extra-label uses of Penicillin G Procaine extend to various clinical situations under veterinary supervision within the context of a valid veterinarian-client-patient relationship (VCPR). These applications may include treatment of neonatal infections, prophylactic use around surgical procedures, and combination therapy with other antimicrobials for mixed infections. Any extra-label drug use requires veterinary oversight and extended withdrawal periods to ensure food safety compliance. Producers should maintain detailed treatment records documenting extra-label applications and extended withdrawal times as directed by the prescribing veterinarian.

Dosing of Penicillin G Procaine follows species-specific recommendations expressed in units per pound or kilogram of body weight, with treatment duration tailored to the specific infection being addressed. For cattle, the standard labeled dose ranges from 3,000 to 6,600 units per pound of body weight (6,600 to 14,520 units per kilogram), administered once daily by intramuscular or subcutaneous injection. Most label recommendations specify treatment for a minimum of 48 hours after clinical signs resolve, with typical treatment courses lasting 3 to 5 days for uncomplicated infections. Severe or chronic infections may require extended treatment durations under veterinary guidance.

Swine dosing typically follows similar unit-per-pound calculations as cattle, with 3,000 to 6,600 units per pound representing the standard range. Young pigs and finishing hogs receive intramuscular injections, with injection volumes limited to prevent excessive tissue irritation at any single site. Treatment of erysipelas in swine often requires the higher end of the dosage range with treatment continuing until clinical improvement is evident and for at least one day beyond resolution of fever and skin lesions.

Sheep and goats require careful attention to dosing calculations due to their smaller body size compared to cattle. The same unit-per-pound dosing applies, but total injection volumes must be distributed across multiple injection sites to avoid exceeding recommended per-site limits. Subcutaneous administration in small ruminants often provides easier access and reduced muscle damage compared to deep intramuscular injection in these smaller animals.

Proper administration technique significantly impacts treatment success and minimizes adverse effects. Before injection, shake the vial thoroughly to resuspend the medication uniformly, as settling occurs during storage. Use appropriately sized needles (typically 16 to 18 gauge for cattle, 18 to 20 gauge for swine and small ruminants) of adequate length to reach the intended tissue depth. For intramuscular injection in cattle, the neck muscles represent the preferred site to avoid carcass damage in meat animals, with injection volumes limited to 10 mL per site. Subcutaneous injection should deposit medication in the loose skin of the neck or behind the shoulder with similar volume limits per injection site.

Aseptic technique during administration prevents introduction of bacteria at the injection site and maintains medication sterility. Cleanse the injection site with alcohol or disinfectant, use sterile needles for each animal or group of animals, and avoid contaminating the vial contents by using transfer needles or drawing medication through a cleaned stopper. Multi-dose vials should be dated when first opened and discarded according to label directions, typically within 28 days of initial entry.

Withdrawal times for Penicillin G Procaine require strict adherence to ensure meat and milk safety. The standard labeled meat withdrawal for cattle is 4 to 10 days depending on the specific product, with slaughter prohibited before this period elapses following the last treatment. Milk withdrawal times typically range from 48 to 96 hours, requiring that milk from treated dairy cows be discarded during treatment and for the specified period afterward. Swine meat withdrawals generally fall in the 5 to 7 day range. Extra-label use mandates extended withdrawal periods as determined by the prescribing veterinarian, often utilizing FARAD (Food Animal Residue Avoidance Databank) resources for guidance on appropriate intervals.

Penicillin G Procaine demonstrates an excellent safety profile in livestock species when administered according to label directions, with adverse effects occurring infrequently in properly dosed animals. The procaine component incorporated into the formulation provides local anesthetic properties that minimize injection site discomfort, improving animal welfare during treatment. Most animals tolerate repeated daily injections well throughout standard treatment courses without significant complications or behavioral changes indicating distress.

Injection site reactions represent the most commonly observed adverse effects following Penicillin G Procaine administration. Transient swelling, firmness, or soreness at the injection site may develop within hours of administration and typically resolves within several days without intervention. More persistent tissue reactions including sterile abscesses, granulomas, or excessive scarring occasionally occur, particularly when injection technique is suboptimal or excessive volumes are deposited at single sites. These lesions may result in trim loss at slaughter, emphasizing the importance of proper administration in meat animals and selection of injection sites that minimize carcass impact.

Procaine toxicity, while uncommon with properly formulated products administered correctly, can occur if medication inadvertently enters the bloodstream through intravascular injection. Signs of procaine reaction include immediate anxiety, muscle tremors, incoordination, vocalization, hyperexcitability, and in severe cases, seizure activity or collapse. These reactions typically prove self-limiting as the procaine is rapidly metabolized, but affected animals should be monitored quietly and protected from injury during the episode. Proper aspiration before injection and avoiding superficial veins reduces the risk of intravascular administration.

Hypersensitivity reactions to penicillin occur rarely in livestock but represent potentially serious adverse events when they develop. Acute anaphylaxis following penicillin injection manifests as respiratory distress, urticaria, facial swelling, weakness, and cardiovascular collapse. Animals with known previous penicillin hypersensitivity should not receive subsequent penicillin injections due to the risk of severe allergic responses. Emergency epinephrine and supportive care equipment should be available when administering injectable antibiotics in case anaphylaxis occurs.

Gastrointestinal disturbances including diarrhea or changes in fecal consistency may develop in some animals receiving penicillin therapy, particularly with extended treatment courses. The disruption of normal intestinal flora by the antibiotic can allow overgrowth of resistant organisms or alteration of fermentation in ruminants. Most cases resolve following treatment completion as normal microbial populations reestablish. Severe or persistent diarrhea warrants veterinary evaluation to rule out secondary complications or superinfection with resistant pathogens.

The primary absolute contraindication for Penicillin G Procaine administration involves known hypersensitivity to penicillin or other beta-lactam antibiotics in the individual animal. Animals that have previously experienced allergic reactions following penicillin exposure face significant risk of severe anaphylaxis with subsequent administration. Although true penicillin allergy remains relatively uncommon in livestock, producers should maintain treatment records that document any adverse reactions, enabling identification of animals that should not receive penicillin in the future.

Certain species restrictions and cautions apply to Penicillin G Procaine use that warrant consideration during treatment planning. While the medication holds approval for cattle, swine, and sheep, specific label instructions may exclude certain production classes or age groups. Products not specifically labeled for dairy cattle in lactation should not be used in milking animals due to milk residue concerns. Similarly, breeding animals near the time of semen collection or embryo transfer may require additional consideration regarding potential impacts on reproductive procedures.

Animals in severely compromised health status require careful evaluation before initiating penicillin therapy. Severely dehydrated animals may demonstrate altered drug distribution and elimination, potentially affecting both efficacy and safety. Animals with significant renal impairment face delayed excretion of penicillin, as the kidneys serve as the primary elimination route for this antibiotic. While accumulation to toxic levels remains unlikely given penicillin's wide safety margin, prolonged tissue residence times may necessitate extended withdrawal periods.

Concurrent administration of bacteriostatic antibiotics represents a relative contraindication due to potential antagonism with penicillin's bactericidal mechanism. Antibiotics such as tetracyclines, chloramphenicol, and macrolides inhibit bacterial protein synthesis and growth, reducing the population of actively dividing bacteria against which penicillin demonstrates maximum efficacy. When clinical circumstances require combination antimicrobial therapy, veterinary guidance ensures appropriate drug selection and dosing to achieve therapeutic goals while minimizing antagonistic interactions.

Penicillin G Procaine interactions with other antimicrobials represent the most clinically significant consideration when planning combination therapy in livestock. The bactericidal mechanism of penicillin depends upon active bacterial cell wall synthesis, which occurs primarily during bacterial growth and division. Bacteriostatic antibiotics including tetracyclines, macrolides, chloramphenicol, and lincosamides inhibit bacterial protein synthesis, effectively arresting bacterial growth. This growth inhibition can theoretically reduce penicillin efficacy by limiting the population of actively dividing bacteria against which cell wall-active agents demonstrate maximum killing activity. Clinical significance of this interaction varies with the specific pathogens involved and disease severity.

Aminoglycoside antibiotics such as gentamicin and streptomycin demonstrate synergistic activity with penicillin against certain bacterial pathogens, particularly enterococci and some gram-negative organisms. The cell wall damage induced by penicillin enhances aminoglycoside penetration into bacterial cells, improving killing of organisms that might demonstrate reduced susceptibility to either agent alone. This combination finds application in treating serious mixed infections under veterinary supervision, though aminoglycoside nephrotoxicity and withdrawal requirements must be carefully considered in food animals.

Ionophore feed additives including monensin, lasalocid, and salinomycin do not demonstrate direct pharmacologic interactions with penicillin in cattle and other ruminants. However, treatment of ill animals receiving ionophore-containing feeds requires attention to the animal's overall health status and appetite. Decreased feed intake during illness naturally reduces ionophore exposure, while recovery and return to normal feeding patterns restores typical intake levels. No dosage adjustments for either penicillin or ionophores are typically required based solely on concurrent use.

Vaccine administration timing relative to antibiotic therapy warrants consideration in herd health management programs. While penicillin does not directly inactivate vaccines, animals fighting active infections may demonstrate suboptimal immune responses to vaccination. Best practices generally recommend separating antibiotic treatment from vaccination when possible, allowing ill animals to recover before immunization. When treatment and vaccination must occur concurrently due to operational constraints, expectations for vaccine efficacy should be tempered and revaccination considered once animals have fully recovered.

Human safety during handling and administration of Penicillin G Procaine requires attention to prevent occupational exposure and potential sensitization. Individuals with known penicillin allergy should avoid handling this medication, as contact exposure or accidental self-injection can trigger allergic reactions ranging from localized skin responses to severe systemic anaphylaxis. All personnel administering injectable penicillin should wear appropriate protective gloves and exercise caution to prevent needlestick injuries. Accidental self-injection warrants immediate medical attention, particularly for individuals with unknown or positive penicillin allergy status.

Food safety represents a paramount concern when using Penicillin G Procaine in food-producing animals. Strict adherence to labeled withdrawal periods ensures that antibiotic residues have depleted to safe levels before meat or milk enters the human food supply. Producers must maintain accurate treatment records documenting the animals treated, medication used, dose administered, treatment dates, and calculated withdrawal dates. Animals must not be sent to slaughter before withdrawal periods elapse, and milk from treated dairy cows must be discarded during treatment and for the specified withholding period. Violations result in regulatory action and undermine consumer confidence in food safety.

Antimicrobial resistance stewardship requires judicious use of penicillin and all antibiotics in livestock production. Penicillin should be reserved for treatment of documented or highly suspected bacterial infections, avoiding routine prophylactic use without clear clinical justification. Appropriate dosing at labeled rates for adequate duration ensures therapeutic concentrations that minimize selection pressure for resistant organisms. Culture and sensitivity testing, while not always practical in field conditions, provides valuable guidance for optimizing antimicrobial selection when treatment failures occur or resistant infections are suspected.

Environmental considerations include proper disposal of unused medication, empty containers, and used needles and syringes. Pharmaceutical waste should not be disposed of through general garbage or wastewater systems where environmental contamination could occur. Follow label directions for container disposal, typically involving triple-rinsing and recycling where programs exist, or disposal through approved pharmaceutical waste collection programs. Needles and syringes require disposal in approved sharps containers to prevent injury and environmental release.

Proper storage between uses maintains medication potency and safety throughout the labeled shelf life. Penicillin G Procaine products require protection from freezing, which can damage the suspension characteristics and potentially alter bioavailability. Storage within the labeled temperature range, typically controlled room temperature or refrigeration depending on the specific product, ensures consistent medication quality. Multi-dose vials should be dated when first accessed and discarded after the labeled in-use period, typically 28 days, to prevent contamination and degradation issues.

Proper storage of Penicillin G Procaine maintains medication stability, sterility, and therapeutic efficacy throughout the product's shelf life. Most formulations require storage at controlled room temperature between 20°C and 25°C (68°F to 77°F), though some products may specify refrigeration. Protection from freezing is essential, as ice crystal formation can irreversibly damage the suspension characteristics, potentially affecting drug release and bioavailability following injection. Storage locations should provide protection from direct sunlight and extreme temperature fluctuations that could accelerate degradation.

Multi-dose vial management requires careful attention to prevent contamination and maintain sterility between uses. Upon first entry, record the date on the vial label to track the in-use expiration period, typically 28 days for most injectable antibiotics. Use of sterile transfer needles or drawing through a cleansed rubber stopper using aseptic technique prevents introduction of environmental bacteria into the vial contents. If the suspension appears discolored, contains particulates other than the normal white medication particles, or fails to resuspend uniformly with shaking, the vial should be discarded.

Disposal of unused medication, expired products, and empty containers must follow environmental protection guidelines and label instructions. Unused penicillin should never be poured down drains, disposed of in household garbage, or released into the environment where antibiotic contamination could occur. Many veterinary practices and agricultural suppliers offer pharmaceutical take-back programs for proper disposal. Empty containers should be triple-rinsed with water, with rinse water applied to the treatment area or disposed of according to label directions. Puncture-resistant sharps containers must be used for all needles and syringes, with disposal through approved medical waste programs.

Cattle breed considerations for Penicillin G Procaine administration primarily involve body size differences affecting dose calculations and injection volume distribution. Large-framed beef breeds including Charolais, Simmental, and Limousin may require higher total doses to achieve therapeutic tissue concentrations, while smaller dairy breeds and heritage cattle receive proportionally lower total amounts based on accurate body weight estimation. Jersey and Guernsey dairy cattle typically weigh significantly less than Holstein counterparts, necessitating careful dose calculation to avoid both underdosing and excessive injection volumes.

Dairy versus beef production systems influence treatment decisions regarding injection site selection and withdrawal time management. Dairy operations must carefully track milk withdrawal periods and ensure treated animals are clearly identified to prevent contaminated milk from entering bulk tanks. Beef cattle treatment emphasizes injection site selection that minimizes carcass trim losses, with neck injection strongly preferred over traditional hip or thigh sites that affect valuable cuts. Young calves and lightweight stocker cattle require particular attention to injection volume limits per site to prevent excessive tissue damage in their smaller muscle masses.

Swine breed and production stage considerations affect Penicillin G Procaine administration in pig operations. Modern lean genetics may demonstrate different drug distribution characteristics compared to heritage or fatty breeds, though clinical significance remains limited. Production stage significantly influences treatment decisions, with breeding stock receiving careful consideration regarding reproductive impacts and market hogs requiring strict withdrawal period adherence. Young nursery pigs require scaled-down doses with attention to small body size and limited injection sites.

Sheep and goat breed diversity creates notable variation in body size that affects dosing calculations. Miniature breeds, hair sheep, and fiber goats span a wide weight range requiring accurate assessment for proper dosing. Small ruminants generally require division of calculated doses across multiple injection sites due to their limited muscle mass compared to cattle. Meat-type lambs and goats destined for slaughter require the same attention to injection site selection and withdrawal periods as beef cattle to ensure food safety and minimize carcass trim losses.

Several related penicillin formulations offer alternative options within the beta-lactam antibiotic class for livestock treatment. Penicillin G Benzathine provides extended-release characteristics that maintain therapeutic concentrations for 3 to 4 days following a single injection, reducing handling frequency for animals requiring prolonged treatment. Combination products containing both procaine and benzathine penicillin deliver immediate peak concentrations from the procaine component while the benzathine portion provides sustained low-level activity. Ampicillin and amoxicillin represent extended-spectrum penicillins with improved activity against certain gram-negative organisms, though their use in food animals requires careful attention to withdrawal periods.

Beyond the penicillin family, numerous other antibiotic classes provide alternatives when penicillin proves ineffective or contraindicated. Oxytetracycline offers broad-spectrum activity against both gram-positive and gram-negative bacteria, with long-acting formulations available for extended treatment intervals. Ceftiofur represents a third-generation cephalosporin with excellent activity against common respiratory and Gram-negative pathogens in cattle and swine. Florfenicol provides an alternative for respiratory disease treatment, particularly in cases involving Pasteurella or Mannheimia species with reduced penicillin susceptibility.

Tulathromycin, tilmicosin, and other macrolide antibiotics serve as alternatives for bovine respiratory disease when gram-positive coverage and convenient single-dose protocols are desired. These medications concentrate in lung tissue and provide extended activity against common respiratory pathogens. Selection among available antibiotics should consider culture and sensitivity results when available, previous treatment history, withdrawal period requirements, and cost-effectiveness for the specific clinical situation. Veterinary consultation supports optimal antimicrobial selection and stewardship goals in livestock production.